TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2-metastatic breast cancer

  1. Rugo, H.S.
  2. Bardia, A.
  3. Tolaney, S.M.
  4. Arteaga, C.
  5. Cortes, J.
  6. Sohn, J.
  7. Marmé, F.
  8. Hong, Q.
  9. Delaney, R.J.
  10. Hafeez, A.
  11. André, F.
  12. Schmid, P.
Aldizkaria:
Future Oncology

ISSN: 1744-8301,  1479-6694

Argitalpen urtea: 2020

Alea: 16

Zenbakia: 12

Orrialdeak: 705-712

Mota: Artikulua

DOI: 10.2217/FON-2020-0163 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus